All eyes on tech earnings

Equities 4 minutes to read

Eleanor Creagh

Australian Market Strategist

Summary:  Risky assets followed the Fed, pushing higher overnight, and setting a firm positive lead for Asia as the Feds ultra-dovish message crushed yields and propelled stocks and gold higher. The Fed maintaining the mantra to do whatever it takes to support the economy and hinting at further action in preparing for the worst, supporting the return of the perpetually bid growth/momentum trade overnight and green lighting yield hunting behaviour, with little regard for economic realities.


Healthcare and technology stocks the biggest gainers on the ASX 200, again following the dovish signals from the Fed, with rates set to remain low for an extended period. Music to the ears of seemingly infinity bound momentum and growth stocks, with the earnings duration pathways whose valuations are boosted by record low rates set to extend for years to come.

However, the “whatever it takes” boost petering out and US futures trading lower, dollar bid smalls with a slight risk off tone creeping into the afternoon session as investors weighed the ever-mounting COVID-19 toll on the global economy, congressional gridlock on the next stimulus bill and the earnings releases from tech titans, Apple, Amazon and Alphabet tonight. Higher cases in Victoria, Tokyo and record deaths in Texas also injecting a dose of reality into the frenzy precipitated by central bank’s bid to remain accommodative at all costs and detach asset prices from reality. This liquidity induced, frenzied behaviour in full view as Robinhood data shows daytraders stampeding into Kodak stock. According to Robintrack data, around 43,000 Robinhood users have added Kodak to their accounts in some form over the past 24 hours as speculation on virus cures runs rife. At one stage overnight, the stock was up almost 700%.

Although the Fed was the big story overnight, Chairman Powell offered up very few surprises, with no major changes to the policy stance and post meeting statement. However, what was offered was a decisive reiteration of current policy settings and a clear commitment that monetary policy will remain expansionary with Powell’s commentaries remaining as dovish as possible without the addition of new “tools”. Powell whilst stopping short of directly tying forward guidance to a specific outcome, hinted at the readiness to strengthen forward guidance shifting to an outright measure down the track, which would include tying future rate increases explicitly to actual inflation reaching/overshooting 2%. The Fed chair was also keen to emphasise the enormous degree of uncertainty that remains with respect to the economy and tie the path of policy to the pandemic and unknown virus outcomes. Essentially forewarning market participants that the Fed is ready to take further action if necessary, and has plenty of room to manoeuvre should the need arise.

Tonight’s 2Q GDP read is likely to confirm a collapse in the US economy of epic proportions at the hands of the global pandemic. However, although the read will no doubt grab headlines, the data is largely backward looking and with the virus resurgence ruling present outcomes the high frequency data will provide a better read on the state of the US economy. Again overnight the Fed chair was quick to point out that this high frequency data has stalled with the resurgence of the virus and recovery momentum appears to faltering, as we have previously noted.

 The true directional focus for risk assets will however most likely come from the mega cap tech earnings. Speculative excesses in technology stocks which have led the charge in the melt up off the March lows have embedded some solid expectations about these companies, which given lofty expectations must be met. With concentration another risk factor, as large cap tech now accounts for almost 40% of the S&P 500, the onus on delivery for broad market sentiment is large.


Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Pty Ltd ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as CFDs and Margin FX products may result in your losses surpassing your initial deposits. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.